<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46814344-D2A0-4C3A-920A-598FC35388D4"><gtr:id>46814344-D2A0-4C3A-920A-598FC35388D4</gtr:id><gtr:name>University of W?rzburg</gtr:name><gtr:address><gtr:line1>Pleicherwall 2</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:department>Medicine Dentistry and Biomedical Sci</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46814344-D2A0-4C3A-920A-598FC35388D4"><gtr:id>46814344-D2A0-4C3A-920A-598FC35388D4</gtr:id><gtr:name>University of W?rzburg</gtr:name><gtr:address><gtr:line1>Pleicherwall 2</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CC56CEB6-29AA-444A-8689-4C70122AB699"><gtr:id>CC56CEB6-29AA-444A-8689-4C70122AB699</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Duprex</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/53F4798C-3079-4801-AF37-F70368EEAA71"><gtr:id>53F4798C-3079-4801-AF37-F70368EEAA71</gtr:id><gtr:firstName>Bertus Karel</gtr:firstName><gtr:surname>Rima</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0501427"><gtr:id>B9F51BDC-5AB1-43EC-8634-EC0C87FDF5DD</gtr:id><gtr:title>The role of translational control in the natural history of measles virus</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501427</gtr:grantReference><gtr:abstractText>Fever in humans is generally unwelcome and we try to alleviate it by taking drugs and shedding clothes. Our study centres on measles virus (MV) which induces a high fever. Viruses evolve alongside their hosts; so whenever the host tweaks its immune system to fight the virus the virus responds by collecting additional genes or mutating existing ones to circumvent this assault. Understanding this race is vitally important. MV has two proteins which are essential for growth and when the virus replicates at 37&amp;deg;C the proteins are produced. However, when MV grows at 39&amp;deg;C, a similar temperature experienced during fever, these proteins are not made. This potentially gives the virus an advantage during fever, since when these proteins are not made the virus can hide within cells and evade detection by the immune system. The work will be led by Bert Rima, who has worked for over 30 years on MV, and Paul Duprex who has genetically modified viruses to study links between their genes and proteins. We are in an ideal position to address this problem because we can both manipulate the virus and have established animal models which allow us to differentiate between disease-causing and non-disease-causing viruses.</gtr:abstractText><gtr:technicalSummary>Fever is a hallmark response to infection. From a physiological perspective, the rise in body temperature is a process which aims to ensure survival of the individual. Endogenous pyrogens such as the cytokines interleukins 1, 6 and tumour necrosis factor act in concert on thermoregulatory centres in the hypothalamus to generate a controlled elevation in temperature.

Co-evolution of host and pathogen is common. As fever is deemed to be an evolutionary adaptation to infection, one may hypothesise that unidentified mechanisms have evolved to capitalise on the innate febrile response to virus infection, similar to the variety of mechanisms that viruses use to abrogate immune responses. Interestingly, this idea has not been studied in any detail and as such both virologists and clinicians have no real understanding of how infectious agents might exploit this response.

Measles virus (MV) provides us with a unique opportunity to study this effect for a number of reasons. First, fever is clinically typical of MV infection; second, we have published that two important structural proteins of the virus are selectively translated at elevated temperatures; third we can manipulate the viral genome by reverse genetics and thereby generate recombinant viruses with altered phenotypes and last we have established a number of animal models which allow us complement in vitro mechanistic studies on selective temperature-sensitive translation with an in vivo pathological assessment.

We propose a four year programme of work which aims to understand the molecular basis for selective temperature-sensitive expression translation (StsT) of the matrix (M) and fusion (F) proteins of MV. This effect has been identified in vaccine viruses and a single wild-type virus. We will determine if it is demonstrable in other wild-type viruses and a closely related animal virus, canine distemper virus. Eukaryotic expression constructs expressing the individual genes will be used to examine StsT in transfected cells and determine if the effect is wholly or partially dependent on the expression of other viral proteins or the generation of an infected state within cells. These approaches will allow us to map the viral sequences which govern StsT and permit us to generate recombinant viruses which have the sequences removed. These viruses will be phenotypically characterised using appropriate animal models to elucidate the in vivo consequences. At a molecular level proteins which recognise the StsT sequences will be identified using proteomic-based approaches.</gtr:technicalSummary><gtr:fund><gtr:end>2010-07-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>633184</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Rotterdam (Erasmus Universitair Medisch Centrum EUR)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Virology</gtr:department><gtr:description>Erasmus University Medical Center , Rotterdam The Netherlands</gtr:description><gtr:id>69C18D8F-9BD4-4E06-A4D6-86B1B0FF7BD7</gtr:id><gtr:impact>paper 18020706</gtr:impact><gtr:partnerContribution>provision of a monkey model and immunological assessment</gtr:partnerContribution><gtr:piContribution>We have provided all recombinant viruses for this collaboration which have been used extensively in the monkey model at Rotterdam. We host visitors from Rotterdam to train them in bio-imaging, immunohistochemistry and pathological assessments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of W?rzburg (Universit?t W?rzburg)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Virology and Immunobiology W?rzburg</gtr:department><gtr:description>Belfast Wuerzburg Partnership</gtr:description><gtr:id>FBB62E86-9045-4DB6-A1D5-208763F59551</gtr:id><gtr:impact>a number of joint publications are in preparation</gtr:impact><gtr:partnerContribution>exchange of ideas and reagents; visits by staff from our group and the two groups in Wuerzburg led by Juergen and Sybille Schneider-Schaulies</gtr:partnerContribution><gtr:piContribution>Long standing exchange of reagents; occasional visits by staff from our group and the Wuerzburg group; supervision of students on visits; exchange of ideas. We organise an annual invitation only meeting of European measles researchers. We critique each other's ideas and formulate a strategy for collaboration.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Models of Disease Grant (G0801001: Illuminating childhood infections)</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5BE3A103-7800-488C-AC4F-EFC8992DF224</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>recombinant viruses that had specific defects in earlier vectors fixed and viruses that express autofluorescent proteins and extar accessory proteins</gtr:description><gtr:id>8E591DB2-F7BA-4DC6-B600-376D910A7692</gtr:id><gtr:impact>better understanding of the roles of accessory proteins and discovery of a potential new accessory protein in measles infection.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>recombinant measles viruses</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D62EDF56-157E-4B83-862F-76CDB6754A2A"><gtr:id>D62EDF56-157E-4B83-862F-76CDB6754A2A</gtr:id><gtr:title>The phosphoprotein genes of measles viruses from subacute sclerosing panencephalitis cases encode functional as well as non-functional proteins and display reduced editing.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/916660f96415bfc4b5f9feb67689aa5f"><gtr:id>916660f96415bfc4b5f9feb67689aa5f</gtr:id><gtr:otherNames>Millar EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8BE84ABD-EF97-4F96-8458-7BDC22AD1422"><gtr:id>8BE84ABD-EF97-4F96-8458-7BDC22AD1422</gtr:id><gtr:title>Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/206e6bfe432f433a7dc924d18a391504"><gtr:id>206e6bfe432f433a7dc924d18a391504</gtr:id><gtr:otherNames>de Swart RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AECB431C-7A4B-4F09-B6D2-933D565E6B96"><gtr:id>AECB431C-7A4B-4F09-B6D2-933D565E6B96</gtr:id><gtr:title>The measles virus replication cycle.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/382db645e41c41e93be6344b897e64c5"><gtr:id>382db645e41c41e93be6344b897e64c5</gtr:id><gtr:otherNames>Rima BK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0070-217X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B0FC6CE-CA16-46D9-8690-C201074FC1CE"><gtr:id>0B0FC6CE-CA16-46D9-8690-C201074FC1CE</gtr:id><gtr:title>The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6129759e49f00144c4b8d4ff35f27a1a"><gtr:id>6129759e49f00144c4b8d4ff35f27a1a</gtr:id><gtr:otherNames>Fehrholz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6AE19D60-1EB7-475B-AC0F-C76D0B5BCCA0"><gtr:id>6AE19D60-1EB7-475B-AC0F-C76D0B5BCCA0</gtr:id><gtr:title>Determination of spontaneous mutation frequencies in measles virus under nonselective conditions.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0d10ae0b5fee7f7d7a790e1b961f1e4"><gtr:id>f0d10ae0b5fee7f7d7a790e1b961f1e4</gtr:id><gtr:otherNames>Zhang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501427</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>